GCCPL has forward integrated from B2B in finished formulations to create their own end user existence felt. Marketing branded generics ethically is the aim of the department and is focused only into pharmaceutical products for use in Interventional Cardiology. This recent 3 year old business wing was developed around an unconventional concept of identifying different products keeping the end use of the basket of products along the same lines of Intraventional Cardiology. This department is growing exponentially and is aimed at being the top player in Intraventional Cardiology in India in the next few years.

Brand Name API Indication Strength
Eptiday – bolus Eptifibatide Treatment of acute coronary syndrome, including patients managed medically and those undergoing percutaneous coronary intervention (PCI), including patients undergoing intracoronary stenting. 20mg / 10ml
Eptiday - infusion Eptifibatide 75mg / 100ml
Bivaday/td> Bivalirudin Bivaday is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). 250mg